A 60-year-old female presented with sudden painful visual loss and photophobia in left eye (LE) since 15 days. LE had undergone cataract surgery eight months back. Visual acuity was 6/6 in right eye, and no perception of light (PL) in LE. Right eye was unremarkable, whereas LE had congested scleral vessels [ Fig. 1a and b]. Anterior chamber showed intense inflammation with perilenticular fluffy exudates. Vitreous cavity was full of yellowish exudates with subretinal exudation seen hazily with ophthalmoscope. Sonography of LE showed vitreous exudates, shallow retinal detachment, and periocular exudation around the optic nerve. Infective sclerouveitis/panophthalmitis was presumed. Investigations revealed neutrophilia (~85%), raised ESR (78 mm/h), and a lung mass/large nodule in left lung [ Fig. 1c ]. After discussion with the pulmonologist, Contrast Enhanced Computed Tomography (CECT) chest and orbits, and Cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA) were ordered. Intensive antifungal regime was started with oral indomethacin suspecting pulmonary aspergilloma-related endogenous infection.
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Two days hence, significantly high c-ANCA (17.69 U/ml) was detected. Later radioimaging revealed multiple cavitary lesions in both lungs (L > R) [ Fig. 1d ] and periscleral inflammation [ Fig. 1e ]. The diagnosis was revised to granulomatosis polyangiitis (GPA). High-dose intravenous steroids for three days and single high-dose cyclophosphamide were given with supportive topical therapy, and later the patient was shifted to similar oral therapy. One month later, she was painless, anterior chamber was clear, and scleritis had dampened with scleral thinning, but vision persisted to be low (PL+). The lung mass had reduced considerably on skiagram.
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Volume 67 Issue 11 GPA is progressive with associated mortality if not treated timely. In total, 11% can have scleritis as initial presentation. [1] [2] [3] This case was marked by the severity of its presentation leading to the initial misdiagnosis of infective etiology. Even the initial blood and imaging workup were suggestive of fungal infection, but lack of risk factors and general condition were against fungal endogenous infection. [4, 5] Continued surveillance with clinical suspicion, aided by aggressive multidisciplinary interaction led to the accurate management.
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